Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1807120 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $12.62Day +4.99%Mkt cap $741M1Y +213.2%Off 52W high −26.8%Vol (1Y) 82.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 951 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest9.1% of sh out |
| Days to cover6.4d |
| 13F net flow (QoQ)−0.87% |
| Top-10 13F concentration66.2% |
| Next report (est.)2026-10-27 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$69.7M |
| ROE−30.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+34.5% |
| 1Y+213.2% |
| 3Y+55.0% |
| 5Y−21.1% |
| Since incept. (ann.)−20.0% |
Total return through 2026-07-30 · series begins 2021-03-26. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)82.1% |
| Ann. volatility (3Y)89.8% |
| Sharpe (1Y)1.85 |
| Sharpe (3Y)0.71 |
| Max drawdown (1Y)−35.6% |
| Max drawdown (3Y)−75.6% |
| Beta (3Y vs SPY)1.55 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SR One Capital Management, LP | 6.5M | $69M | 10.58% | +0.0% |
| RA CAPITAL MANAGEMENT, L.P. | 3.0M | $32M | 4.82% | +103.4% |
| Point72 Asset Management, L.P. | 2.7M | $29M | 4.41% | −49.3% |
| BAKER BROS. ADVISORS LP | 2.6M | $28M | 4.19% | +15.8% |
| BlackRock, Inc. | 2.1M | $23M | 3.46% | +0.8% |
| Logos Global Management LP | 1.9M | $21M | 3.16% | −22.0% |
| Driehaus Capital Management LLC | 1.7M | $19M | 2.83% | +47.9% |
| Vivo Capital, LLC | 1.6M | $17M | 2.62% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-04-28 | −$0.29 | — | $0 | — |
| 2025-09-30 | 2025-11-05 | −$0.30 | — | — | — |
| 2025-06-30 | 2025-08-07 | −$0.34 | — | — | — |
| 2025-03-31 | 2025-05-07 | −$0.31 | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-27 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
